Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FPURD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,166
Award facts
- Contract value 100% obligated
- $4,165.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,165.86 by the Defense Logistics Agency on October 24, 2025, for the supply of Nexplanon 68 mg implants. This firm fixed-price delivery order, with an ultimate completion date of November 17, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036.
The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide pharmaceutical and medical supply support to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's product portfolio encompasses a comprehensive range of pharmaceuticals, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals. As a critical supplier within the federal pharmaceutical supply chain, the contractor has demonstrated substantial performance through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, positioning it as one of multiple regional prime vendor contractors supporting DoD healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FPURD?
SPE2DB26FPURD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FPURD worth?
The government has obligated $4,166 on SPE2DB26FPURD.
Is contract SPE2DB26FPURD an order under another contract?
Yes. SPE2DB26FPURD is a delivery order under SPE2DB25D9303, an indefinite delivery contract.
Was contract SPE2DB26FPURD competed?
The extent of competition for SPE2DB26FPURD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award